SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-054625
Filing Date
2024-05-07
Accepted
2024-05-07 16:35:51
Documents
81
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q crbp-20240331.htm   iXBRL 10-Q 1378524
2 EX-31.1 crbp-ex31_1.htm EX-31.1 15607
3 EX-31.2 crbp-ex31_2.htm EX-31.2 15715
4 EX-32.1 crbp-ex32_1.htm EX-32.1 8995
5 EX-32.2 crbp-ex32_2.htm EX-32.2 8943
  Complete submission text file 0000950170-24-054625.txt   7914297

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crbp-20240331.xsd EX-101.SCH 1302353
84 EXTRACTED XBRL INSTANCE DOCUMENT crbp-20240331_htm.xml XML 1371087
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37348 | Film No.: 24922615
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)